Ullrich; Axel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ullrich; Axel.The latest application filed is for "kinases as targets for anti-diabetic therapy".

Company Profile

0.67.53

Ullrich; Axel - Munich DE
Ullrich; Axel - Munchen N/A DE
Ullrich; Axel - San Francisco CA US
Ullrich; Axel - Muenchen DE
Ullrich; Axel - Martinreid DE
Ullrich; Axel - Muenich DE
Ullrich; Axel - Munchen 40 DE
Ullrich; Axel - Portola Valley CA
Ullrich; Axel - Martinsried DE
Ullrich, Axel - Martinsreid DE
Ullrich, Axel - Martinsried bei Munich DE
Ullrich; Axel - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for treatment of diabetes by a small molecule inhibitor for GRK5 Grant 9,458,463 - Falcenberg , et al. October 4, 2	2016-10-04
Quinoline derivatives as AXL kinase inhibitors Grant 9,206,130 - Ullrich , et al. December 8, 2	2015-12-08
Quinolinyloxyphenylsulfonamides Grant 9,169,241 - Ullrich , et al. October 27, 2	2015-10-27
Inhibitors of her3 activity Grant 9,011,851 - Ullrich , et al. April 21, 2	2015-04-21
Pharmaceutically active compounds as Axl inhibitors Grant 8,999,982 - Schultz-Fademrecht , et al. April 7, 2	2015-04-07
Kinases As Targets For Anti-diabetic Therapy App 20150079108 - Falcenberg; Mathias ; et al.	2015-03-19
Quinolinyloxyphenylsulfonamides App 20140336191 - Ullrich; Axel ; et al.	2014-11-13
Quinolinyloxyphenylsulfonamides Grant 8,685,971 - Ullrich , et al. April 1, 2	2014-04-01
Pharmaceutically Active Compounds As Axl Inhibitors App 20140018365 - Schultz-Fademrecht; Carsten ; et al.	2014-01-16
Kinases As Targets For Anti-diabetic Therapy App 20130336986 - Falcenberg; Mathias ; et al.	2013-12-19
Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation Grant 8,591,903 - Ullrich , et al. November 26, 2	2013-11-26
Human nerve growth factor by recombinant technology Grant 8,557,768 - Gray , et al. October 15, 2	2013-10-15
Diagnosis And Prevention Of Cancer Cell Invasion App 20130084300 - ULLRICH; Axel ; et al.	2013-04-04
Quinolinyloxyphenylsulfonamides App 20120277231 - Ullrich; Axel ; et al.	2012-11-01
Diagnosis and prevention of cancer cell invasion Grant 8,277,802 - Ullrich , et al. October 2, 2	2012-10-02
Method of diagnosing an RTK-hyperfunction induced disorder Grant 8,043,806 - Ullrich , et al. October 25, 2	2011-10-25
Rodent Cancer Model For Human Fgfr4 Arg388 Polymorphism App 20110179505 - Ullrich; Axel ; et al.	2011-07-21
Cell line comprising vector encoding truncated FLK-1 receptor Grant 7,964,399 - Ullrich , et al. June 21, 2	2011-06-21
Quinoline Derivatives As Axl Kinase Inhibitors App 20110092503 - Ullrich; Axel ; et al.	2011-04-21
Her3 As A Determinant For The Prognosis Of Melanoma App 20110033482 - Ullrich; Axel ; et al.	2011-02-10
Cancer-related Protein Kinases App 20110008347 - Ullrich; Axel ; et al.	2011-01-13
Use Of Inhibitors For The Treatment Of Rtk-hyperfunction-induced Disorders, Particularly Cancer App 20100184686 - Ullrich; Axel ; et al.	2010-07-22
FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs App 20100143386 - Ullrich; Axel ; et al.	2010-06-10
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer Grant 7,678,372 - Ullrich , et al. March 16, 2	2010-03-16
EGF RECEPTOR TRANSACTIVATION BY G-PROTEIN-COUPLED RECEPTORS REQUIRES METALLOPROTEINASE CLEAVAGE OF proHB-EGF App 20100048684 - Ullrich; Axel ; et al.	2010-02-25
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Grant 7,632,645 - Ullrich , et al. December 15, 2	2009-12-15
Inhibition of TACE or amphiregulin for the Modulation of EGF Receptor Signal Transactivation App 20090292007 - Ullrich; Axel ; et al.	2009-11-26
Fgfr Agonists App 20090123462 - Bange; Johannes ; et al.	2009-05-14
Method for screening FGFR-4 agonists Grant 7,531,304 - Bange , et al. May 12, 2	2009-05-12
Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation Grant 7,524,495 - Ullrich , et al. April 28, 2	2009-04-28
Products and methods for treating PTP lar diseases App 20090074722 - Ullrich; Axel ; et al.	2009-03-19
Extracellular signal-regulated kinase sequences and methods of production and use Grant 7,371,828 - Lechner , et al. May 13, 2	2008-05-13
Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods App 20080051556 - Ullrich; Axel ; et al.	2008-02-28
Pyruvate-kinase As A Novel Target Molecule App 20080021116 - Ullrich; Axel ; et al.	2008-01-24
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer Grant 7,297,774 - Ullrich , et al. November 20, 2	2007-11-20
Novel megakaryocytic protein tyrosine kinase 1 App 20060263877 - Ullrich; Axel ; et al.	2006-11-23
Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation App 20060246448 - Ullrich; Axel ; et al.	2006-11-02
Preparation of human IGF via recombinant DNA technology Grant RE39,355 - Lee , et al. October 17, 2	2006-10-17
Nucleic acids encoding BDP-1 Grant 7,074,589 - Ullrich , et al. July 11, 2	2006-07-11
DNA encoding MCK-10, a novel receptor tyrosine kinase App 20060147372 - Ullrich; Axel ; et al.	2006-07-06
Inhibition of stress-induced ligand-dependent egfr activation App 20060148694 - Ullrich; Axel ; et al.	2006-07-06
Receptor-type phosphotyrosine phosphatase-kappa antibodies Grant 7,056,508 - Schlessinger , et al. June 6, 2	2006-06-06
Methods for diagnosis and treatment of MDK1 signal transduction disorders App 20060099708 - Ciossek; Thomas ; et al.	2006-05-11
Megakaryocytic protein tyrosine kinase I Grant 7,037,677 - Ullrich , et al. May 2, 2	2006-05-02
Methods for diagnosis and treatment of MDK1 signal transduction disorders Grant 7,034,112 - Ciossek , et al. April 25, 2	2006-04-25
Diagnosis and prevention of cancer cell invasion App 20050186571 - Ullrich, Axel ; et al.	2005-08-25
Use of egfr transactivation inhibitors in human cancer App 20050176633 - Ullrich, Axel ; et al.	2005-08-11
Fgfr agonists App 20050153878 - Bange, Johannes ; et al.	2005-07-14
Antibodies directed against signal regulator proteins Grant 6,913,894 - Buhring , et al. July 5, 2	2005-07-05
Megakaryocytic protein tyrosine kinase I Grant 6,908,984 - Ullrich , et al. June 21, 2	2005-06-21
MCK-10 a novel receptor tyrosine kinase Grant 6,897,029 - Ullrich , et al. May 24, 2	2005-05-24
FLK-1 is a receptor for vascular endothelial growth factor App 20050107321 - Ullrich, Axel ; et al.	2005-05-19
Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein Grant 6,872,699 - Ullrich , et al. March 29, 2	2005-03-29
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer App 20040235776 - Ullrich, Axel ; et al.	2004-11-25
Inhibitors of her3 activity App 20040197332 - Ullrich, Axel ; et al.	2004-10-07
Protein tyrosine phosphatase PTP20 and related products and methods Grant 6,797,501 - Aoki , et al. September 28, 2	2004-09-28
Nucleic acid encoding CLK2 protein kinases Grant 6,797,513 - Ullrich , et al. September 28, 2	2004-09-28
Pyruvate-kinase as a novel target molecule App 20040152648 - Ullrich, Axel ; et al.	2004-08-05
Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer Grant 6,770,742 - Ullrich , et al. August 3, 2	2004-08-03
Method for identifying functional nucleic acids App 20040110177 - Ullrich, Axel ; et al.	2004-06-10
Pyk2 phosphorylation by her3 induces tumor invasion App 20040082510 - Ullrich, Axel ; et al.	2004-04-29
Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer App 20040067885 - Ullrich, Axel ; et al.	2004-04-08
Extracellular signal-regulated kinase sequences and methods of production and use App 20030229209 - Lechner, Cornelia ; et al.	2003-12-11
Secretory tyrosine phosphatases from mycobacteria App 20030180304 - Ullrich, Axel ; et al.	2003-09-25
PTP-S31: a novel protein tyrosine phosphatase App 20030138932 - Moller, Niels Peter Hundahl ; et al.	2003-07-24
SIRP proteins and uses thereof App 20030109002 - Ullrich, Axel ; et al.	2003-06-12
Methods for diagnosis and treatment of MDK1 signal transduction disorders App 20030104407 - Ciossek, Thomas ; et al.	2003-06-05
Treatment of diabetes mellitus and insulin receptor signal transduction App 20030091551 - Ullrich, Axel ; et al.	2003-05-15
Protein tyrosine phosphatase PTP20 and related products and methods App 20030073120 - Aoki, Naohita ; et al.	2003-04-17
SIRP proteins and uses thereof Grant 6,541,615 - Ullrich , et al. April 1, 2	2003-04-01
Novel megakaryocytic protein tyrosine kinases App 20030054527 - Ullrich, Axel ; et al.	2003-03-20
Antibodies directed against signal regulator proteins App 20030054415 - Buhring, Hans-Jorg ; et al.	2003-03-20
Novel megakaryocytic protein tyrosine kinases App 20020192790 - Ullrich, Axel ; et al.	2002-12-19
Method of treating tumor cells by inhibiting growth factor receptor function App 20020192211 - Hudziak, Robert M. ; et al.	2002-12-19
Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods App 20020169303 - Ullrich, Axel ; et al.	2002-11-14
Method for culturing recombinant cells App 20020142467 - Mather, Jennie P. ; et al.	2002-10-03
Nucleic acids encoding CLK protein kinases App 20020106771 - Ullrich, Axel ; et al.	2002-08-08
Novel Receptor-type Phosphotyrosine Phosphatase-kappa App 20020082397 - Schlessinger, Joseph ; et al.	2002-06-27
Flk-1 is a receptor for vascular endothelial growth factor App 20020081650 - Ullrich, Axel ; et al.	2002-06-27
Monoclonal antibodies directed to the HER2 receptor Grant 6,399,063 - Hudziak , et al. June 4, 2	2002-06-04
Monoclonal antibodies directed to the HER2 receptor Grant 6,387,371 - Hudziak , et al. May 14, 2	2002-05-14
Treatment of diabetes mellitus and insulin receptor signal transduction App 20020022023 - Ullrich, Axel ; et al.	2002-02-21
HER2 extracellular domain Grant 6,333,169 - Hudziak , et al. December 25, 2	2001-12-25
Treatment of platelet derived growth factor related disorders such as cancers Grant 6,331,555 - Hirth , et al. December 18, 2	2001-12-18
Megakaryocytic protein tyrosine kinases Grant 6,326,469 - Ullrich , et al. December 4, 2	2001-12-04
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis Grant 6,177,401 - Ullrich , et al. January 23, 2	2001-01-23
Monoclonal antibodies directed to the HER2 receptor Grant 6,165,464 - Hudziak , et al. December 26, 2	2000-12-26
Extracellular signal-regulated kinase, sequences, and methods of production and use Grant 6,030,822 - Lechner , et al. February 29, 2	2000-02-29
HER2 extracellular domain Grant 6,015,567 - Hudziak , et al. January 18, 2	2000-01-18
Treatment of platelet derived growth factor related disorders such as cancers Grant 5,990,141 - Hirth , et al. Nov	1999-11-23
Receptor-type phosphotyrosine phosphatase-.kappa. Grant 5,856,162 - Schlessinger , et al. January 5, 1	1999-01-05
Methods for identifying modulators of insulin receptor phosphorylation Grant 5,856,111 - Ullrich , et al. January 5, 1	1999-01-05
FLK-1 is a receptor for vascular endothelial growth factor Grant 5,851,999 - Ullrich , et al. December 22, 1	1998-12-22
Monoclonal antibodies directed to the HER2 receptor Grant 5,772,997 - Hudziak , et al. June 30, 1	1998-06-30
Monoclonal antibodies directed to the her2 receptor Grant 5,770,195 - Hudziak , et al. June 23, 1	1998-06-23
Monoclonal antibodies directed to the HER2 receptor Grant 5,725,856 - Hudziak , et al. March 10, 1	1998-03-10
In vivo tumor detection assay Grant 5,720,937 - Hudziak , et al. February 24, 1	1998-02-24
Monoclonal antibodies directed to the HER2 receptor Grant 5,720,954 - Hudziak , et al. February 24, 1	1998-02-24
Process for diagnosing non-insulin-dependant diabetes mellitus Grant 5,719,022 - Seedorf , et al. February 17, 1	1998-02-17
Treatment of platelet derived growth factor related disorders such as cancers Grant 5,700,823 - Hirth , et al. December 23, 1	1997-12-23
Monoclonal antibodies directed to the HER2 receptor Grant 5,677,171 - Hudziak , et al. October 14, 1	1997-10-14
Monoclonal antibodies against c-kit and method of detecting a malignancy using c-kit specific antibodies Grant 5,545,533 - Bartke , et al. August 13, 1	1996-08-13
Extracellular signal-regulated kinase, sequences, and methods of production and use Grant 5,459,036 - Lechner , et al. October 17, 1	1995-10-17
Human nerve growth factor by recombinant technology Grant 5,288,622 - Gray , et al. * February 22, 1	1994-02-22
Human nerve growth factor by recombinant technology Grant 5,169,762 - Gray , et al. December 8, 1	1992-12-08
Receptors for efficient determination of ligands and their antagonists or agonists Grant 5,030,576 - Dull , et al. July 9, 1	1991-07-09
Method of detecting truncated epidermal growth factor receptors Grant 4,933,294 - Waterfield , et al. June 12, 1	1990-06-12
Novel receptors for efficient determination of ligands and their antagonists or agonists Grant 4,859,609 - Dull , et al. August 22, 1	1989-08-22
Insulin receptor Grant 4,761,371 - Bell , et al. August 2, 1	1988-08-02
Recombinant bacterial plasmids containing the coding sequences of insulin genes Grant 4,652,525 - Rutter , et al. March 24, 1	1987-03-24
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms Grant 4,440,859 - Rutter , et al. April 3, 1	1984-04-03